Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Surgical oncology

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.suronc.2008.09.003PMID 19027288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevance.

  2008cited by this paper
• Jass staging is a predictor of outcome following "curative" resection of Dukes' B colorectal carcinoma.

  2006cited by this paper
• Colon cancer and apoptosis.

  2006cited by this paper
• Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma

  2005cited by this paper
• Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

  2005cited by this paper
• Cancer incidence and mortality in France over the period 1978-2000.

  2003cited by this paper
• Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

  2001cited by this paper
• Microsatellite instability in colorectal cancer.

  2000cited by this paper
• Evidence for post‐transcriptional down‐regulation of the apoptosis‐related gene bcl‐2 in human colorectal cancer

  2000cited by this paper
• Microsatellite instability in colorectal cancer.

  2000cited by this paper
• bcl‐2 protein expression is associated with better prognosis in colorectal cancer

  1999cited by this paper
• Evaluation of multiple bio‐pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl‐2

  1999cited by this paper
• Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia

  1999cited by this paper
• The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence.

  1999cited by this paper
• Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases.

  1999cited by this paper
• Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.

  1998cited by this paper
• Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

  1998cited by this paper
• Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer

  1998cited by this paper
• Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas.

  1997cited by this paper
• Prognostic markers for colorectal cancer: Expression of P53 and BCL2

  1997cited by this paper
• Prognostic significance of Bcl‐2 expression and p53 nuclear accumulation in colorectal adenocarcinoma

  1997cited by this paper
• Dna ploidy, cell proliferation and genetic alterations in colorectal cancer: Correlation with clinicopathological features

  1996cited by this paper
• Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance

  1996cited by this paper
• The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.

  1995cited by this paper
• bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.

  1995cited by this paper
• Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival.

  1995cited by this paper
• Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.

  1995cited by this paper
• bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas.

  1995cited by this paper
• Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators.

  1994cited by this paper
• Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes.

  1993cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper

• Immunohistochemical study of hypoxia-inducible factor 1 alpha, B cell lymphoma-2, and cathepsin D expressions in colorectal carcinoma: a trial to find diagnostic approach for detecting high risk cases among Egyptian patients

  2025cites this paper
• Bcl-2 expression and image analysis of premalignant and malignant colonic lesions

  2024cites this paper
• MicroRNA 133A Regulates Cell Proliferation, Cell Migration, and Apoptosis in Colorectal Cancer by Suppressing CDH3 Expression

  2023cites this paper
• Prognostic value of combining E-cadherin, p53, Bcl-2 and Bcl-xL expression and survival in Tunisian colorectal adenocarcinoma patients.

  2022influential citation
• The Effects of siRNA-Mediated Gene Silencing of Alpha-7 Nicotinic Acetylcholine Receptors on Drug Resistance to Oxaliplatin in Colorectal Cancer Cells

  2022cites this paper
• Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis.

  2021cites this paper
• Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene

  2021cites this paper
• Frequency of overexpression of Her2/neu in colorectal adenocarcinomas– A hospital based cross-sectional study

  2020cites this paper
• Integrative Systematic Review Meta-analysis and Bioinformatics Identifies MicroRNA-21 and its Target genes as Biomarkers for Colorectal Adenocarcinoma.

  2019cites this paper
• Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer

  2018cites this paper
• Nuclear Localisation of Autophagic p62 and Associated Cytoplasmic Beclin-1 and Bcl-2 Expressions in Adenomas and Adenocarcinomas of the Colorectal Regions

  2018cites this paper
• Long noncoding RNA FAL1 promotes proliferation and inhibits apoptosis of human colon cancer cells

  2018cites this paper
• Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological Correlations

  2018cites this paper
• Correlation study of GAPDH, Bcl-2, and Bax protein immunoexpression in patients with colorectal adenocarcinoma

  2018cites this paper
• T4N0 colon cancers should be treated like T3N1 disease.

  2018cites this paper
• SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells

  2017cites this paper
• Necroptosis in cancer: An angel or a demon?

  2017cites this paper
• miR-10a and miR-204 as a Potential Prognostic Indicator in Low-Grade Gliomas

  2017cites this paper
• A novel feature ranking method for prediction of cancer stages using proteomics data

  2017cites this paper
• Bcl-2 Analysis in Colorectal Carcinoma- An Immunohistochemical Study

  2017influential citation
• FoxM1: Repurposing an oncogene as a biomarker.

  2017cites this paper
• Does the Presence of Endometrial Polyp Predict Colorectal Polyp?

  2016cites this paper
• The prognostic significance of p53, Bax, Bcl-2 and cyclin E protein overexpression in colon cancer - an immunohistochemical study using the tissue microarray technique.

  2016cites this paper
• High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer

  2016cites this paper
• Expression of cathepsin D and BCL-2 in colorectal carcinoma, and their correlation with proliferation indices

  2016cites this paper
• Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer.

  2015cites this paper
• Reasons for cancer metastasis: A holistic perspective (Review)

  2015cites this paper
• Terpenoids Isolated From the Shoot of Plectranthus hadiensis Induces Apoptosis in Human Colon Cancer Cells Via the Mitochondria-Dependent Pathway

  2015cites this paper
• Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.

  2015cites this paper
• Tumor Diameter Is an Easy and Useful Predictor of Recurrence in Stage II Colorectal Cancer

  2015cites this paper
• The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells

  2015cites this paper
• A system biology approach for understanding the miRNA regulatory network in colon rectal cancer

  2015cites this paper
• Bcl-2 together with PI3K p110α regulates cell morphology and cell migration

  2015cites this paper
• ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.

  2015cites this paper
• Reasons for cancer metastasis: A holistic perspective.

  2015cites this paper
• Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer

  2014cites this paper
• Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines

  2014cites this paper
• MTA1—a stress response protein: a master regulator of gene expression and cancer cell behavior

  2014cites this paper
• DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence

  2014cites this paper
• Protein phosphatase 1 and its complexes in carcinogenesis.

  2014cites this paper
• Automated quantitative analysis of tissue microarray of 443 patients with colorectal adenocarcinoma: low expression of Bcl-2 predicts poor survival.

  2014cites this paper
• Impact of Phytolacca americana Extracts on Gene Expression of Colon Cancer Cells

  2014cites this paper
• Immunohistochemical Expression of HER 2 / neu in Colorectal Carcinoma

  2013cites this paper
• Development of method for three-point data estimation and SVR-QSAR model to screen anti cancer leads.

  2013cites this paper
• Understanding the role of NRF2-regulated miRNAs in human malignancies

  2013cites this paper
• Apoptosis drives cancer cells proliferate and metastasize

  2013cites this paper
• Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

  2013cites this paper
• The effect of novel compounds on cell survival and apoptosis in colon cancer cell lines

  2013cites this paper
• LEBANESE AMERICAN UNIVERSITY The Effect of StarD 13 on Colorectal Cancer Proliferation and Invasion

  2013cites this paper
• Ki 67-BCL 2 index in prognosis of malignant peritoneal mesothelioma

  2013cites this paper
• Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer

  2012cites this paper
• Assessment of Bcl-2 oncoprotein expression in colorectal epithelial neoplasms An Immunohistochemical study

  2012cites this paper
• In Vitro Cancer Research on Ancient Herbal Remedies: A Changing Trend

  2012cites this paper
• Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

  2012cites this paper
• Identification of Clinical Markers in Colon Cancer by Tissue Based in situ Proteomics

  2012cites this paper
• Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer

  2012cites this paper
• A systems biology approach to the global analysis of transcription factors in colorectal cancer

  2012cites this paper
• Disparate clinicopathological correlations of p53 and Bcl-2 in colorectal cancer.

  2011cites this paper
• Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results

  2011cites this paper
• Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer.

  2011cites this paper
• Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.

  2010cites this paper
• Multidrug Resistance-1 Gene Expression and Its Relation to Apoptosis in Acute Leukemia Patients

  2010cites this paper
• Global analysis of miRNA target genes in colon rectal cancer

  2010cites this paper